HIV seropositivity in i.v. drug users in Ohio.
Seligman-PJ; Campbell-RJ; Keeler-GP; Halpin-TJ
Am J Publ Health 1988 Jun; 78(6):720
In this letter to the editor information was presented concerning the incidence of human immunodeficiency virus (HIV) infection among intravenous (iv) drug users in Ohio. The Ohio Department of Health (ODH) undertook a study of methadone clinic participants with nine licensed treatment centers participating from the seven largest metropolitan areas in Ohio. Of clients attending the centers between April and November of 1986, blood samples were obtained from 509 individuals with iv drug use in their histories. Of these, seven (1.4 percent) were seropositive for HIV. The sexual orientation of the whole group was primarily heterosexual, with eight males giving a history of homosexual activities. Of the seven HIV cases, three gave histories of having shared a needle in New York City since 1981. Being Black or Hispanic and having shared needles in New York City appear to be factors associated with increased risk for HIV positivity in Ohio. According to the authors, educational efforts to prevent HIV transmission in the drug using population of Ohio with apparently low HIV seroprevalence offers a reasonable opportunity to limit the spread of acquired immune deficiency syndrome.
NIOSH-Author; Disease-transmission; Infectious-diseases; Acquired-immune-deficiency-syndrome; AIDS-virus; Viral-infections; Blood-analysis; Racial-factors; Epidemiology
American Journal of Public Health